Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Approved by FDA and EMA for metastatic Breast Cancer / Mammacarcinoma (HER2+); EMA also explicitly states locally recurrent unresectable breast cancer; regimen uses Docetaxel + Pertuzumab + Trastuzumab in patients without prior anti-HER2 therapy or chemotherapy for metastatic disease
…